“Myelofibrosis: Transplantation in the Era of JAK Inhibitor”

Friday, January 13^th, 2017

Walker Auditorium

12:30 p.m. – 1:30 p.m.

Lunch available on a first come, first serve basis

Presented by:

Ankit Kansagra, MBBS

Resident, Blood and Marrow Transplant

Mayo Clinic Rochester

Learning Objectives:

Upon conclusion of this program, participants should be able to:

1. Identify the role of allogeneic transplantation in Myelofibrosis

2. Appropriate patient selection and management of transplant complication in Myelofibrosis

3. Identify the integration of JAK inhibitor in allogeneic transplantation

“Speaker, Doctor Ankit Kansagra, and Course Director, Doctor James Foran, have no financial relationships to disclose or intentions to discuss off-label/ investigational use of a commercial product device.”

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. College of Medicine, Mayo Clinic designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.  Physicians should only claim credit commensurate with the extent of their participation in the activity. Please direct all inquiries for non-physician CEU’s to Clinical Education at (3-0326) 

Credit is available to Mayo Clinic staff only.